Fundus albipunctatus is an inherited retinal disease, meaning it is passed down through families via changes (mutations) in specific genes. Understanding the genetic basis of this condition is essential for patients and their families, particularly when it comes to family planning and assessing the risk for future generations.
The vast majority of fundus albipunctatus cases are caused by mutations in the RDH5 gene. This gene provides the instructions for making an enzyme called 11-cis retinol dehydrogenase 5. This enzyme is a critical component of the "visual cycle" in the retina, responsible for recycling vitamin A derivatives so the eyes can detect light, especially in dark environments. When the RDH5 gene is mutated, the enzyme does not function correctly, leading to the characteristic night blindness and retinal flecks associated with the disease. In very rare cases, mutations in other genes, such as RLBP1 or RPE65, can cause similar symptoms.
Fundus albipunctatus is inherited in an autosomal recessive pattern. "Autosomal" means the gene is located on one of the non-sex chromosomes, so it affects males and females equally. "Recessive" means that a person must inherit two mutated copies of the gene—one from each parent—to develop the condition.
Individuals who have only one mutated copy of the RDH5 gene and one normal copy are called "carriers." Carriers typically have normal vision and do not show any symptoms of fundus albipunctatus because the one normal gene produces enough of the necessary enzyme.
When two carriers have a child, there is a 25% chance with each pregnancy that the child will inherit two mutated genes and develop fundus albipunctatus. There is a 50% chance the child will inherit one mutated gene and be a carrier like the parents, and a 25% chance the child will inherit two normal genes and be neither affected nor a carrier.
For individuals diagnosed with fundus albipunctatus, genetic testing is highly recommended. A confirmed genetic diagnosis not only solidifies the clinical diagnosis but also opens the door to potential future gene-specific therapies and clinical trials.
Genetic counseling is a vital resource for affected individuals and their families. A genetic counselor can help interpret test results, explain the exact inheritance risks, and discuss family planning options. Patients should consult their healthcare provider to get a referral to a certified genetic counselor to navigate these important decisions.